Aktywność biologiczna modyfikownych nukleozydów. Część 2

Journal Title: Wiadomości Chemiczne - Year 2018, Vol 72, Issue 5

Abstract

Part II of the review describes biological activities of nucleosides modified in the position 2’ and/or 3’ of a sugar moiety including 2’- and/or 3’-deoxy, 2’,3’-dideoxydidehydro and 2’-β-C-methylated derivatives. Analogues with a changed configuration in the sugar residue and others sugar modifications will be a subject of the part III of the review. Together with the part I it would be a short but possibly comprehensive review of nucleosides’ biological activities. In the group of analogues modified in the position 2’ and/or 3’ of the sugar moiety the following derivatives among others are listed: AZT (zidovudine) – one of the key nucleoside reverse transcriptase inhibitors (NRTI), which are the core of highly active antiretroviral therapy (HAART) against virus HIV; didanosine (ddI) – another potent NRTI with medical importance; stavudine – FDA approved NRTI; zalcitabine – historically important NRTI, however, because of a high mitochondrial toxicity is no longer in use; puromycin – a wide spectrum antibiotic which causes premature chain termination during translation, isolated from Streptomyces alboniger; gemcitabine – chemotherapy medication developed by Eli Lilly and Company and used to treat ovarian, breast, pancreas, bladder cancer and non-small cell lung carcinoma; cordycepin – the most intriguing analogue extracted from Cordyceps sp. known to traditional Chinese medicine (TCM) for centuries, possessing multi-activity against different cancer types; cladribine – used in the treatment of chronic lymphocytic leukemia, cutaneous T-cell lymphoma, hairy cell leukemia and non-Hodgkin’s lymphomas; valopicitabine – a prodrug form of 2’-C-methylcytidine, which was a promising HCV treatment agent, however, it was held during clinical trials and finally sofosbuvir developed by M.J. Sofia from Pharmasset Inc.– a ProTide prodrug form of 2’-deoxy-2’-fluoro-β-C-methyluridine 5’-monosphate, which revolutionized HCV infection therapy.

Authors and Affiliations

Maurycy Szlenkier

Keywords

Related Articles

Molekularne materiały magnetyczne

The „molecular” term appears more and more often in the materials chemistry. The Nobel Prize in 2016 was awarded to Jean-Pierre Sauvage, Sir J. Fraser Stoddart and Bernard R. Feringa „for the design and synthesis of mole...

Zastosowania enzymów z tkanek zwierzęcych w syntezie organicznej i biokatalizie. Część I. Hydrolazy

This work presents systematically enzymes which can be obtained form animal tissue and their applications in synthesis of pharmaceuticals and nonracemic organic compounds. It lays out similarities in procedures of isolat...

Metody chemicznej ligacji w syntezie peptydów i białek. Część 2

Proteins are synthesized only by living organisms. Today, we are able to receive them by recombinant protein expression in bacterial cells. This technique is very useful and gives satisfactory amount of desirable materia...

Elektrooptyczny efekt Kerra w chemii

The electro-optical Kerr effect finds wide application in conformational analysis of molecules and molecular aggregates [1–5], particularly in cases where the standard X-ray and NMR techniques cannot be used. For instanc...

W pogoni za sadzą

Soot is produced simultaneously by the incomplete combustion of fossil fuels. Investigations of soot elemination methods are currently focused on light fuel oil boilers. The overview of various transition metal propertie...

Download PDF file
  • EP ID EP567939
  • DOI -
  • Views 164
  • Downloads 0

How To Cite

Maurycy Szlenkier (2018). Aktywność biologiczna modyfikownych nukleozydów. Część 2. Wiadomości Chemiczne, 72(5), 245-264. https://europub.co.uk./articles/-A-567939